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Comparative Toxicity and Tissue
Distribution of Lead Acetate in
Weanling and Adult Rats
by J. 1. Rader,t J. T. Peeler* and K. R. Mahaffey*
The relative toxicity of low doses of lead acetate provided steadily in drinking water or by
mouth once per week was studied in weanling and adult rats. Free erythrocyte protoporphyrin
and urinary 8-aminolevulinic acid levels were measured, as well as lead levels in blood and
kidney. The accumulation of lead in brain tissue and in bone (femur) was measured to
determine the effect of age and schedule of administration on tissue distribution and retention
of lead. Total intakes of lead during the 60-week experimental period were: weanling and adult
rats exposed to drinking water supplemented with 200 ,g of lead acetate/ml: 127 + 10 mg and
160 ± 16 mg, respectively; weanling and adult rats dosed with lead acetate orally once per week:
132 mg and 161 mg, respectively. Increased toxic effects of lead in the weanling animals were
apparent in most of the parameters measured (urinary 8-aminolevulinic acid and blood, brain,
femur and kidney lead levels). This pattern was observed in weanling rats exposed to lead
steadily through drinking water or dosed orally with an equivalent quantity of lead once per
week. Lead levels in blood were highly correlated with the accumulation of lead in brain,
femur, and kidney tissue in both groups ofweanling rats. In adult rats, significant correlations
between blood lead and kidney lead and between blood lead and femur lead were found only in
the rats receiving lead steadily in drinking water.
Introduction
The higher incidence of acute lead intoxication
among children than among adults has been recog-
nized for a number of years (1, 2). Children are
exposed to higher levels of lead than are adults
because of behavioral patterns (for example, char-
acteristic mouthing of objects, pica). In addition,
exposures to lead from sources such as air, food,
and water are higher on a per kilogram of body
weight basis for children than for adults. Although
a portion of the elevated incidence of lead toxicity
is due to excessive lead exposure, recent studies
indicate that there are also significant age-related
differences in the physiological handling of lead.
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These include age-specific variations in absorption,
retention, and tissue distribution of lead. There is
also a higher prevalence among children than
adults of specific nutritional deficiencies (for exam-
ple, those of calcium and iron) known to increase
susceptibility to lead toxicity (3-7).
Defining the metabolic, physiological and behav-
ioral characteristics that contribute to the increased
susceptibility of the young to lead toxicity (1, 8)
may be valuable in the prevention of lead poison-
ing. One emphasis of such research is to define
factors that influence the sensitivity to lead of the
rapidly developing nervous system of the young.
The identification of conditions of lead exposure
which may damage the central nervous system
while indicators used for screening (for example,
blood lead) remain at levels thought to be safe is of
particular importance. Although the effects of lead
on the central nervous system have been reviewed
(9-12), the level of lead exposure at which detri-
mental effects begin has not yet been determined
(13).
187In spite of the widespread use of animal model
systems (14-18), few data are available that relate
equivalent quantities and schedules of lead expo-
sure to differences in tissue lead levels in young
and adult animals. One purpose of the present
study was to determine the degree to which blood
lead levels are predictive of tissue lead levels in
young and adult rats exposed to lead on different
dosage schedules. Another purpose was to deter-
mine the effects of age on tissue retention and
distribution of lead as shown by accumulation of
lead in brain and bone.
Materials and Methods
Animals
Weanling and adult male albino Sprague-Dawley
rats (Blue Spruce Farms, Altamont, N.Y.) were
divided into groups and fed a nutritionally ade-
quate, purified diet (AIN-76, 19) (preparedbyZeigler
Brothers, Gardners, Pa.) for 6 weeks.
Exposure to Lead
One group each ofweanling and adult rats served
as the controls (group I). One group of weanling
and one group of adult rats received a drinking
solution containing 200 ,ug of lead/ml (as lead ace-
tate) (group II). Water consumption in these groups
was measured throughout the experimental peri-
od, and lead intakes were calculated on the basis of
milligrams of lead/kilogram of body weight/week.
A single oral dose of lead acetate in water equiva-
lent to that consumed by rats receiving lead
acetate-supplemented drinking water was admin-
istered to each animal in the third groups ofwean-
ling and adult rats on a weekly basis (group III).
All rats were housed individually in suspended
stainless steel cages; food and water were supplied
ad libitum.
Twenty-four hour urine collections for the de-
termination of 8-aminolevulinic acid (8-ALA) were
made during the fifth week of the study. Urine
was collected in foil-covered 50-mi Erlenmeyer flasks
containing 0.25 ml of glacial acetic acid. Samples
were stored in the dark at 50 C for one week
before assay. At sacrifice, rats were anesthetized
with Nembutal (50 mg/kg ofbody weight) and blood
was collected by cardiac puncture. Vacutainers from
lots previously established as being contaminated
with not more than 0.10 ,ug oflead (Environmental
Sciences Associates, Bedford, Mass.) were used
for collection of blood samples for lead analysis.
Kidneys, femurs, and brains were obtained by dis-
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section, freed ofadheringtissues, and fresh weights
were recorded.
Analytical Methods
Urinary b-ALA was determined by the method
of Davis and Andelman (20). Free erythrocyte pro-
toporphyrins (FEP) were measured by using the
method of Piomelli (21). Complete blood counts
and differential white cell determinations were per-
formed by Metpath Laboratories, Cincinnati, Ohio.
Lead was determined in blood, brain, femur, and
kidney samples using anodic stripping voltammetry
(Environmental Sciences Associates, Bedford,
Mass.).
Results
Adult rats consumed 25% more of the lead-
supplemented water during the 6-week experimen-
tal period than did the weanling rats (799 ± 78 ml
for group II adults versus 636 ± 50 ml for group II
weanlings; p < 0.005). Total intake of lead by
group II adult rats was 159.8 ± 15.5 mg compared
to 127.1 ± 9.9 mg for group II weanling rats (p <
0.005). Exposure to lead acetate, calculated on the
basis ofmilligrams oflead/kg/week, was considera-
bly greater in the weanling rats (Tables 1 and 2).
Growth was not affected by the level of lead expo-
sure which occurred during the study.
Summaries of weight gain, hematological values
and tissue lead concentrations for weanling and
adult rats exposed to lead acetate are shown in
Tables 1 and 2, respectively. Percent coefficients
of variation are also listed. Levels of lead in blood
and brain ofboth weanling and adult control groups
were substantially less than among lead-dosed an-
imals. The ranges of blood lead levels for both
weanling and adult control rats were < 3-13 ,ug/dl.
Blood lead values of < 3 ,ug/dl were obtained for 12
of 17 (71%) weanling control rats and 10 of 16
(63%) adult control rats. Ranges of brain lead lev-
els for weanling and adult control rats were <
0.007-0.052 ,ug/gand < 0.005-0.047 ,ug/g, respective-
ly. Five of 18 (28%) weanling control brain lead
concentrations were < 0.007 R±g/g, and 13% (2 of
16) of adult control brain lead concentrations were
< 0.006 pRg/g. A mean value could not be computed
for three of these four measurements.
Coefficients of variation, representing variation
amongindividual rats within each group, were large
for some ofthe parameters measured: 37-102% for
brain lead values, 30-97% for kidney lead, 21-45%
for femur lead, and 29-55% for b-ALA. Percent
coefficients of variation were 6-28 and 5-15 for
Environmental Health PerspectivesTable 1. Lead intake, weight gain, hematological values and tissue lead concentrations in weanling rats exposed to lead
acetate.a
Group I, Group II, Group III,
Parameter Control (% CV) Pb in water (% CV) Pb once/week (% CV)
Lead intake, mg/kg/week
Lead intake, mg/kg/week
Week 1 - 134±22 144±16
2 - 115±9 117±13
3 - 104±10 104±15
4 - 100±0 102±14
5 - 98±11 101±12
6 - 83±22 85±11
Initial body weight, g 78± 10 (10) 79±8 (10) 79±9 (12)
Final body weight, g 342±28 (28) 337±21 (6) 325±39 (12)
Brain weight, g 1.99±0.20 (10) 1.92±0.09 (5) 1.87±0.12 (6)
Femur weight, g 0.86±0.06 (7) 0.80±0.09 (11) 0.80±0.08 (10)
Kidney weight, g 1.43±0.15 (11) 1.56±0.18 (12) 1.52±0.18 (12)
Hemoglobin, g/dl 15.2±1.6 (10) 14.1±2.1 (15) 14.7±1.1 (8)
Hematocrit, % 43.0±4.7 (11) 41.7±6.1 (15) 42.3±3.4 (8)
FEP, ,ug/dl 26±9 (34) 39z10 (26) 35±11 (32)
b-ALA, ,ug/24 hr 109±32 (29) 261 ± 143 (55) 245± 132 (54)
Blood lead, ,ug/dl b 33±12 (36) 21±7 (32)
Brain lead, ,ug/g c 0.946±0.964 (102) 0.358±0.138 (39)
Kidney lead, p.g/g 0.143 ±0.138 (97) 10.78±7.32 (68) 4.67± 1.52 (33)
Femur lead, ,ug/g 7±2 (21) 171±78 (45) 95±28 (30)
aValues represent means ± SD. n = 17 animals (group I), 15 animals (groups II, III). % CV: Percent coefficient of variation.
bRange < 3-13 ,ug/dl; 71% of values < 3 ,g/dl.
cRange < 0.007-0.052 ,ug/g; 28% of values < 0.007 ,ug/g.
Table 2. Lead intake, weight gain, hematological values and tissue lead concentrations in adult rats exposed to lead acetate.a
Group I, Group II, Group III,
Parameter Control (% CV) Pb in water (% CV) Pb once/week (% CV)
Lead intake, mg/kg/week
Lead intake, mg/kg/week
Week 1 63±8 62±3
2 - 72±14 67±4
3 - 68±16 68±4
4 - 64±13 64±4
5 - 63±7 63±4
6 - 59±9 59±4
Initial body weight, g 328±25 (8) 329±21 (6) 338± 19 (6)
Final body weight, g 458±33 (7) 468±31 (7) 475±35 (7)
Brain weight, g 2.16±0.10 (5) 2.03±0.14 (7) 2.12±0.15 (7)
Femur weight, g 1.11±0.09 (8) 1.12±0.09 (8) 1.17±0.07 (6)
Kidney weight, g 1.66±0.17 (10) 1.96±0.17 (9) 1.83±0.20 (11)
Hemoglobin, g/dl 15.5±1.4 (9) 14.7±0.8 (5) 14.9±0.9 (6)
Hematocrit, % 45.0±4.6 (10) 41.5±3.0 (7) 42.6±3.2 (8)
FEP, ,ug/dl 37±11 (31) 43±8 (20) 38±12 (31)
b-ALA, ,ug/24 hr 80±4 (30) 159±71 (45) 117±37 (32)
Blood lead, ,ug/dl b 24±4 (18) 15±5 (33)
Brain lead, R.g/g 0.020±0.014c (70) 0.340±0.127 (37) 0.253±0.139 (55)
Kidney lead, ,ug/g 0.076±0.048 (71) 6.50±1.92 (30) 2.75±0.81 (30)
Femur lead, ,ug/g 8±2 (21) 59±14 (23) 36±15 (42)
aValues represent means ± SD. n = 16 animals (group I), 15 animals (groups II, III). % CV: Percent coefficient of variation.
bRange <3-13 ,ug/dl; 63% of values < 3 Rg/dl. cRange < 0.005-0.047,ug/g; two of16 values were < 0.006,ug/g and estimates ofzero were used forthese values in calculation ofthe
mean.
measurements ofweight and hematological parame- ance (22) showed a significant different (a = 0.05)
ters, respectively. among treatments for both weanling and adult lead
Despite the magnitude of some ofthe coefficients measurements. A summary of the results of the
of variation, the results from an analysis of vari- univariate analysis ofvariance is shown in Table 3.
December 1981 189Table 3. Summary of Duncan's test from the univariate analysis ofvariance.
Weanling rats Adult rats
Lead daily Lead daily
Parameter Control Lead once/week in water Control Lead once/week in water
Initial body wt, g 78 79 79 328 338 329
Final body wt, g 342 325 337 458 475 468
Brain wt, g 1.99 1.87a 1.92 2.16 2.12 2.03a
Femur wt, g 0.86 0.80 0.80 1.11 1.17 1.12
Kidney wt, g 1.43 1.52 1.56 1.66 1.83a 1.96a
Hemoglobin, g/dl 15.2 14.7 14.1 15.5 14.9 14.7
Hematocrit, % 43.0 42.3 41.7 45.0 42.6 41.5a
FEP, ,ug/dl 26 35a 39a 37 38 43
b-ALA, ,ug/24 hr 109 245a 261a 80 117a 1590
Blood lead, p.g/dl c 21a 33a,b c 15a 24a,b
Brain lead, ,ug/g c 0.358a 0.946a,b 0.020 0.253a 0.3400
Kidney lead, ,ug/g 0.143 4.67a 10 79a,b 0.07 2.75a 6.50a,b
Femur lead, ,ug/g 7 95a 171ab 8 36a 590
aSignificantly different from control at a = 0.05 level.
bSignificantly different from value for other treatment group (within same age group) at a = 0.05 level.
CMeans could not be calculated for these values; more than 20% of values < x.
Differences among mean values were determined
by Duncan's test (23). In general, daily exposure
to lead via drinking water resulted in the highest
lead content in blood, brain, kidney, and femur for
both weanling and adult rats. Values resulting from
both lead treatments were significantly different
from corresponding values in the untreated control
groups. This was true despite the variations noted
above and the slight differences in brain weights
(weanlings, adults) and kidney weights (adults)
(Table 3). A significant reduction in hematocrit
was observed only in adult rats exposed to lead
daily via drinking water. FEP levels were signifi-
cantly elevated only in lead-exposed weanling rats;
8-ALA levels were elevated in all four groups of
lead-exposed rats.
The hypothesis that the two schedules of lead
exposure were equivalent was also tested using a
multivariate analysis of variance (MANOVA) (24).
Five variables (blood, brain, kidney and femur lead
and urinary 5-ALA) were included in the analysis.
The means were significant (ot = 0.05), confirming
the univariate analysis.
The relationships between blood lead values and
concentrations of lead in brain, femur, and kidney
are shown in Figures 1-3, respectively. Correla-
tions among the lead variables were examined by
computing linear regressions (22) ofblood lead ver-
sus brain, femur and kidney lead levels for the two
schedules of lead exposure and for the two age
groups. The correlation coefficients, slopes, stan-
dard deviations of slopes, and an F-ratio resulting
from the regression analyses are presented in Table
4. Significant F ratios, indicative of a linear rela-
tionship, were found in both weanling groups for
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all parameters examined. In adult rats, significant
correlations were found between blood lead-femur
lead and blood lead-kidney lead in rats receiving
lead daily via drinking water, and between blood
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FIGURE 3. Relationship between blood lead and kidney lead
levels in weanling ( o) and adult (-_) rats exposed to lead
acetate in drinking water (left panel) or by a single weekly
oral administration (right panel). Linear correlation coefficients
and results of regression analyses are presented in Table 4.
Environmental Health Perspectives
9 &/
*0 0 c
00
_* 0 &
I
IO
I
Pb once wk
II30C
25C
20C
(a
= 150
E
U.
100
50
0 20 40 60 20 40 60
Blood lead pg/di
FIGURE 2. Relationship between blood lead and femur lead
levels in weanling ( o) and adult (-_) rats exposed to
lead acetate in drinking water (left panel) or by a single
weekly oral administration (right panel). Linear correlation
coefficients and results ofregression analyses are presented
in Table 4.
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FIGURE 3. Relationship between blood lead and kidney lead
levels in weanling(- o) and adult (-0) ratsexposed to lead
acetate in drinking water (left panel) or by a single weekly
oral administration (right panel). Linear correlation coefficients
and results of regression analyses are presented in Table 4.
Table 4. Summary of regression analyses for the dependence of tissue lead concentration on blood lead concentration in
weanling and adult rats exposed to lead acetate in water.
Standard
Correlation deviation of
Relationship Group/age coefficient r Slope slope F-ratioa t-valueb
Brain lead-blood lead (Fig. 1) Lead in water 3.96C
Weanlings 0.699 0.0566 0.0161 12.42c
Adults 0.229 0.0066 0.0078 0.72
Lead once per week 2.82c
Weanlings 0.796 0.0161 0.0034 22.46c
Adults -0.037 -0.0010 0.0079 0.02
Femur lead-blood lead (Fig. 2) Lead in water 5.67c
Weanlings 0.910 5.923 0.7490 62.53c
Adults 0.627 1.919 0.6609 8.43c
Lead once per week 4.94c
Weanlings 0.867 3.558 0.5679 39.26c
Adults -0.016 -0.050 0.8618 0.003
Kidney lead-blood lead (Fig. 3) Lead in water 1.29
Weanlings 0.585 0.332 0.1279 6.75c
Adults 0.432 0.181 0.1051 2.98c
Lead once per week 2.16c
Weanlings 0.509 0.109 0.0512 4.54c
Adults 0.024 0.004 0.0462 0.O1C
'A significant F-ratio indicates that the null hypothesis (Ho: slope = 0) is rejected.
bt-Tests were performed to examine the hypothesis that estimates of slopes ofweanling and adult values are equal.
CSignificant at a = 0.05 level.
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December 1981 191lead-kidney lead in rats receiving lead once per
week. Blood lead values of weanling animals were
much more likely to be indicative of high lead
levels in brain, femur, and kidney than were adult
blood lead levels. The t-test values (Table 4) confirm
this observation, indicating that the slopes for the
weanling groups were significantly higher than those
for the adult estimates in five of the six parame-
ters examined. t-Test values were also calculated
for comparisons of slopes of regression lines ob-
tained in weanling rats exposed to lead on a daily
basis or by weekly oral administration. The slopes
were significantly different, indicating that blood
lead levels are more likely to be indicative of high
body burdens of lead when exposure is constant
than when exposure is intermittent. t-Values for
comparisons of slopes between the two weanling
groups were: blood lead versus brain lead, t =
3.49;'blood lead versus femur lead, t = 5.35; blood
lead versus kidney lead, t = 2.29. All values were
significant at the a = 0.05 level.
Discussion
Young animals are more sensitive to the toxic
effects of lead than juvenile or adult animals (3,
25-27). The increased susceptibility of young ani-
mals is due in part to their increased capacity to
absorb lead from the gastrointestinal tract (3, 4,
27-29). Such observations have been extended to
include young children (1, 5, 10, 30, 31). In addi-
tion to increased lead retention, age-related differ-
ences in tissue distribution also contribute to the
enhanced sensitivity of the young to lead poison-
ing. In the present study, comparison of total tis-
sue lead levels with the amount of lead ingested
indicated that the femurs ofweanling rats exposed
to lead acetate in drinking water contained 0.11%
(mean value) of the ingested dose. Femurs of the
comparable group ofadult rats retained 0.04% (mean
value) ofthe ingested lead. The more rapid forma-
tion ofbone in young animals and the incorporation
of lead into the newly formed bone contribute to
this increased retention. The same pattern was
observed for accumulation oflead in brain, although
absolute brain lead levels were considerably lower
than femur or kidney lead levels. Mean brain lead
retention as percent of ingested dose was approx-
imately 3-fold higher in weanling rats receiving
lead in drinking water (0.0014%) than in the cor-
responding group of adult rats (0.0004%).
The results of the present study indicate that
when immature and adult rats consume drinking
water containing the same concentration of lead,
younger animals are exposed to considerably greater
quantities oflead relative to body weight than are
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the older animals. Although the weanling rats in
the present study ingested less lead (127-132 mg)
than did the adult animals (160-161 mg), the in-
creased toxic effects oflead in the younger animals
are apparent from the data presented in Tables 3
and 4. Accumulation oflead in the brain and femur
of the immature animals is especially pronounced.
When an equivalent dose oflead was administered
to young or adult animals on a weekly basis, a
similar pattern was observed, with the manifesta-
tions oflead toxicity being more pronounced in the
younger animals.
In young animals exposed to lead, the hemato-
poietic and nervous systems appear to be the criti-
cal target organs (i.e., those organs in which the
toxic metal first accumulates to an extent which
leads to adverse effects on the health ofthe whole
animal). In the weanling rats in the present study,
both FEP and urinary b-ALA excretion increased
in response to lead exposure. The magnitude of
the increase in urinary bALA excretion was greater
than that for FEP. However, in adult animals,
FEP levels did not change significantly, but uri-
nary excretion of b-ALA increased in response to
lead exposure.
Inhibition by lead of 8-aminolevulinate dehydra-
tase (ALA dehydratase) activity in various tissues
results in increased urinary excretion of the sub-
strate b-ALA. Among the parameters examined in
the present study, urinary ALA excretion was the
most sensitive indicator oflead effect in both wean-
ling and adult rats. Mean blood lead values of 15
,ug/dl in adult rats and 21 ,ug/dl in weanling rats
were associated with significant increases in ALA
excretion. We observed in the present study that
urinary ALA excretion was higher in both groups
of lead-exposed weanling rats than in the corres-
ponding groups ofadult rats (Table 3). Our results
do not reveal if ALA dehydratase activity is dif-
ferentially inhibited in various tissues of weanling
and adult rats. In vitro comparison of ALA dehy-
dratase activity in tissues of normal and lead-
exposed rabbits reported by Gibson and Goldberg
(32) indicated that the activity of the enzyme was
reduced in brain, liver, kidney and bone marrow of
the lead-treated animals. In the lead-treated rab-
bits, the enzymes in brain and liver were more
sensitive to inhibition by lead than were those in
kidney and bone marrow. The ALA dehydratase
activity of brain appears to be especially sensitive
to lead. A 42% inhibition of ALA dehydratase ac-
tivity occurred when the mean brain lead level was
2.3 Rug/g, while a 50% reduction in the activity of
the kidney enzyme occurred with a mean tissue
lead level of29.9 ,ug/g (32).
In the present study, we observed that free
Environmental Health Perspectiveserythrocyte protoporphyrins were significantly el-
evated only in the lead-exposed weanling rats (Table
3). As noted in Tables 1 and 2, the weanling rats
were exposed to higher levels of lead on a mil-
ligram/kilogram/week basis than were the adult rats.
The lowest mean blood lead value at which eleva-
tions in FEP were measured was 21 ,ug/dl in the
group of weanling animals exposed to lead acetate
once per week. FEP levels in adult rats receiving
lead acetate daily in drinking water (mean blood
lead concentration 24 ,ug/dl) were not significantly
elevated. These observations suggest that the blood
lead concentration associated with a significant el-
evation in FEP is lower for weanling rats than for
adult animals. A corresponding age-related (chil-
dren versus adults) difference in the blood lead
level at which elevations in FEP are observed has
also been reported in human studies (6).
Considerable information has been obtained in
experimental animals on the effects on the nervous
system of exposure to lead (10, 12, 33).
Statistical analysis of the correlation between
blood lead and brain lead values in the present
study (Table 4 and Fig. 1) shows that these pa-
rameters are highly correlated in weanling rats
but not in the adult animals. The data in the litera-
ture relating dose oflead to accumulation oflead in
brain tissue are based on acute studies. Goldstein
et al. (17) observed that 24 hr after a single admin-
istration of 210Pb to 4-week-old rat pups, the con-
centration of lead in blood and brain was directly
proportional to the dose. In a recent study of the
relationship between brain lead and blood lead in
adult rats exposed to lead-supplemented drinking
water, Savolainen and Kilpio (34) found that these
lead values were proportional during 11 days of
treatment. Differences between these authors' ob-
servations and the lack of such a proportionality in
the adult animals in the present study may be due
to the considerably higher lead doses used by
Savolainen and Kilpio (34) (50-fold higherthan those
used in the present study) or by the shorter dura-
tion of their study (11 days versus 42 days in the
present study).
In a study of the effects of lead on the energy
metabolism ofthe brain, Bull et al. (35) found that
brain lead levels averaging 0.41 ,ug/g (range 0.34-0.52
Rug/g) and higher resulted in significant inhibition
of potassium-stimulated respiration in rat cerebral
cortex slices. Brain lead concentrations in this range
were found in three ofthe four lead-treated groups
in the present study and would be expected to
cause impairments in brain function similar to those
described by Bull et al. (35).
Figure 1 illustrates lead accumulation in the brain
as related to blood lead levels. Retention of lead
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by brain persists after blood lead levels fall (14, 17,
36). When intake of lead is episodic (as in the
group III rats), the concentration of lead in blood
may not be an accurate measure of the amount of
lead actually accumulated in brain tissue; progres-
sive accumulation may occur without pronounced
elevations in blood lead levels. Although consider-
able information has been obtained on the effects
of large doses of lead, more knowledge is needed
to determine the consequences oflong-tern (chron-
ic) deposition of lead in the brain. Adult animals
and/or humans are beyond the critical developmen-
tal periods which make young animals particularly
vulnerable to the neurotoxic effects of lead; how-
ever, the adult nervous system is still susceptible
to lead toxicity (33).
Statistical analyses ofcorrelations between blood
lead and femur lead (Table 4 and Fig. 2) show that
these parameters are highly correlated in weanling
rats receiving lead acetate-supplemented water or
an equivalent quantity of lead once per week. A
weaker correlation was observed in adult rats re-
ceiving lead-supplemented water, but no correla-
tion was found in the adult rats receiving lead
intermittently.
Lead accumulation in the skeleton accounts for
the largest fraction of the total body burden of
lead (94-95% in adults and approximately 70% in
young children) (37). Whereas pools oflead in blood
and soft tissues turn over rapidly, turnover oflead
in the skeleton is considerably slower; the resi-
dence time of lead in bone may be as long as 30
years (37, 38). At the present time, neither the
role of skeletal lead per se nor its function in re-
equilibration processes between blood and soft tis-
sues is fully understood.
A number of factors may cause a redistribution
of lead within the body. For example, conditions
such as dietary deficiencies, hormonal imbalances,
physiological stresses, or metabolic bone diseases
mayresult in some skeletaldemineralization. Under
such circumstances, skeletal lead may be released
to the blood and soft tissues. Lead accumulated in
the skeleton of the young animal would become a
potential hazard if mobilized to blood and soft tis-
sues during adult life. Direct toxic effects on bone
metabolism may result from long-term accumula-
tion of lead. Betts et al. (39) observed changes in
bone density in 93% of children whose blood lead
was treater than 60 ,ug/dl and in 24% of children
with blood lead between 37 and 60 ,ug/dl. Bone
formation was disturbed when beagle dogs were
fed low doses of lead over a 6-month period. [Av-
erage blood lead values at the end of the study
were 55 ,ug/dl (40).]
Few data are available on dose-response relation-
193ships for renal function impairment caused by lead
(41). Intranuclear inclusion bodies have been ob-
served in kidneys at renal lead concentrations of
10 ,ug/g (42). In a previous study (43), we observed
rare intranuclear inclusion body formation, inflam-
matory cell changes, and cloudy swelling in renal
tubular cells in 35% of young rats with mean renal
lead levels of 13 ,ug/g.
In the present study, the accumulation oflead in
the kidneys was highly correlated with blood lead
levels in weanling rats exposed to lead in their
drinking water (Fig. 3 and Table 4). Lower corre-
lations were observed in adult rats receiving lead
in drinking water and in weanling rats dosed with
lead once per week. The relationship between blood
lead levels and renal effects of lead is poorly doc-
umented. Inclusion body formation in renal tubu-
lar cells will occur when blood lead levels are in
the range of40-80 pug/dl (44). In our previous study
(43), mean blood lead values for rats with histolog-
ical evidence of kidney damage were 68-72 ,ug/dl.
Dose-response relationships derived from animal
studies cannot be translated directly into implica-
tions for human exposures to the same compound.
However, some qualitative inferences may be drawn
from the present study: When exposed to identical
sources of lead contamination, younger rats show
more pronounced manifestations of lead intoxica-
tion than older rats; when exposures to low levels
of lead are intermittent, the toxic effects of the
metal are decreased, but are still more apparent in
the young animals than in the older animals.
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